Combo of Two Monoclonal Antibody Treatments Cut Hospitalisation Among High Risk Covid Patients, Says Lancet Study

on
The study found that at the end of 28 days, 1.6 per cent of those treated were hospitalised versus 4.8 per cent of those who had not been treated. This translated to 60-70 per cent relative reduction in hospitalisation among treated patients, according to the researchers.

from Top Lifestyle News- News18.com https://ift.tt/3t8pqi7

Comments

Post a Comment